Association of the time course of Chinese visceral adiposity index accumulation with cardiovascular events in patients with hypertension

被引:7
|
作者
Wu, Yuntao [1 ]
Xu, Wenqi [1 ,2 ]
Guo, Lu [1 ,2 ]
Li, Wenjuan [1 ,2 ]
Zhang, Lisha [1 ,2 ]
Gao, Lishu [3 ]
Zhu, Chenrui [1 ]
Chen, Shuohua [1 ]
Lin, Liming [1 ]
Wu, Shouling [1 ]
机构
[1] Kailuan Gen Hosp, Dept Cardiol, Tangshan 063000, Peoples R China
[2] North China Univ Sci & Technol, Grad Sch, Tangshan, Peoples R China
[3] Tangshan Peoples Hosp, Dept Endocrinol, Tangshan, Hebei, Peoples R China
关键词
Chinese visceral adiposity index; Cumulative measurement; Time course; Adverse cardiovascular event; Visceral fat; MYOCARDIAL-INFARCTION; BLOOD-PRESSURE; GLOBAL BURDEN; RISK; DISEASE; OBESITY; EPIDEMIOLOGY; TRAJECTORIES; CHOLESTEROL; GLUCOSE;
D O I
10.1186/s12944-023-01852-w
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
BackgroundThe Chinese visceral adiposity index (CVAI), a simple surrogate measure of visceral fat, is significantly associated with cardiovascular disease (CVD) risk in the general population. This study aimed to evaluate the association of cumulative CVAI (cumCVAI) exposure and its accumulation time course with CVD risk among patients with hypertension.MethodsThis prospective study involved 15,350 patients with hypertension from the Kailuan Study who were evaluated at least three times in the observation period of 2006 to 2014 (2006-2007, 2010-2011, and 2014-2015) and who were free of myocardial infarction and stroke before 2014. The cumCVAI was calculated as the weighted sum of the mean CVAI for each time interval (value x time). The time course of CVAI accumulation was categorized by splitting the overall accumulation into early (cumCVAI(06 - 10)) and late (cumCVAI(10 - 14)) accumulation, or the slope of CVAI versus time from 2006 to 2014 into positive and negative.ResultsDuring the 6.59-year follow-up period, 1,184 new-onset CVD events were recorded. After adjusting for confounding variables, the hazard ratios (HRs) and 95% confidence intervals (CIs) for CVD were 1.35 (1.13-1.61) in the highest quartile of cumCVAI, 1.35 (1.14-1.61) in the highest quartile of the time-weighted average CVAI, 1.26 (1.12-1.43) in those with a cumulative burden > 0, and 1.43 (1.14-1.78) for the group with a 10-year exposure duration. When considering the time course of CVAI accumulation, the HR (95% CI) for CVD was 1.33 (1.11-1.59) for early cumCVAI. When considering the combined effect of cumCVAI accumulation and its time course, the HR (95% CI) for CVD was 1.22 (1.03-1.46) for cumCVAI & GE; median with a positive slope.ConclusionsIn this study, incident CVD risk depended on both long-term high cumCVAI exposure and the duration of high CVAI exposure among patients with hypertension. Early CVAI accumulation resulted in a greater risk increase than later CVAI accumulation, emphasizing the importance of optimal CVAI control in early life.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Association of the time course of Chinese visceral adiposity index accumulation with cardiovascular events in patients with hypertension
    Yuntao Wu
    Wenqi Xu
    Lu Guo
    Wenjuan Li
    Lisha Zhang
    Lishu Gao
    Chenrui Zhu
    Shuohua Chen
    Liming Lin
    Shouling Wu
    Lipids in Health and Disease, 22
  • [2] The Association of Visceral Adiposity with Cardiovascular Events in Patients with Peripheral Artery Disease
    Cronin, Oliver
    Bradshaw, Barbara
    Iyer, Vikram
    Cunningham, Margaret
    Buttner, Petra
    Walker, Philip J.
    Golledge, Jonathan
    PLOS ONE, 2013, 8 (12):
  • [3] Visceral adiposity index and risks of cardiovascular events and mortality in prevalent hemodialysis patients
    Chen, Hung-Yuan
    Chiu, Yen-Ling
    Chuang, Yi-Fang
    Hsu, Shih-Ping
    Pai, Mei-Fen
    Yang, Ju-Yeh
    Peng, Yu-Sen
    CARDIOVASCULAR DIABETOLOGY, 2014, 13
  • [4] VISCERAL ADIPOSITY INDEX AND RISKS OF CARDIOVASCULAR EVENTS AND MORTALITY IN PREVALENT HEMODIALYSIS PATIENTS
    Chen, Hung-Yuan
    Chiu, Yen-Ling
    Hsu, Shih-Ping
    Pai, Mei-Fen
    Yang, Ju-Yeh
    Wu, Hon-Yen
    Peng, Yu-Sen
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 281 - 281
  • [5] Visceral adiposity index and risks of cardiovascular events and mortality in prevalent hemodialysis patients
    Hung-Yuan Chen
    Yen-Ling Chiu
    Yi-Fang Chuang
    Shih-Ping Hsu
    Mei-Fen Pai
    Ju-Yeh Yang
    Yu-Sen Peng
    Cardiovascular Diabetology, 13
  • [6] The visceral adiposity index and lipid accumulation product as predictors of cardiovascular events in normal weight subjects
    Darroudi, Susan
    Soflaee, Sara Saffar
    Hosseini, Zeinab Sadat
    Farmad, Maryam Safari
    Mirshafiei, Hassan
    Andalibi, Mohammad Sobhan Sheikh
    Eslamiyeh, Mostafa
    Donyadideh, Ghazaleh
    Aryan, Reihaneh
    Toosi, Mansoureh Sadat Ekhteraee
    Talkhi, Nasrin
    Esmaily, Habibollah
    Samadi, Sara
    Mohammadpour, Amir Hooshang
    Rad, Mina Akbari
    Ferns, Gordon A.
    Ghayour-Mobarhan, Majid
    Moohebati, Mohsen
    CLINICAL NUTRITION ESPEN, 2022, 52 : 190 - 197
  • [7] Association of the Chinese visceral adiposity index with marrow adiposity in postmenopausal females
    Zuo, Xiaoyong
    Miao, Zeyang
    Xu, Run
    Shi, Dan
    Chang, Shixin
    Li, Guanwu
    Luo, Peng
    FRONTIERS IN ENDOCRINOLOGY, 2025, 16
  • [8] The visceral adiposity index predicts cardiovascular events both in cardiovascular disease patients with and in those without diabetes
    Mader, Arthur
    Saely, Christoph
    Vonbank, Doz. Alexander
    Heinzle, Christine
    Zanolin-Purin, Daniela
    Larcher, Barbara
    Leiherer, Andreas
    Muendlein, Doz Axel
    Drexel, Heinz
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2019, 49 : 73 - 74
  • [9] THE VISCERAL ADIPOSITY INDEX PREDICTS CARDIOVASCULAR EVENTS BOTH IN CARDIOVASCULAR DISEASE PATIENTS WITH AND IN THOSE WITHOUT DIABETES
    Saely, C. H.
    Vonbank, A.
    Heinzle, C.
    Purin, D.
    Larcher, B.
    Mader, A.
    Leiherer, A.
    Muendlein, A.
    Drexel, H.
    ATHEROSCLEROSIS, 2019, 287 : E135 - E135
  • [10] The visceral adiposity index predicts cardiovascular events both in cardiovascular disease patients with and in those without diabetes
    Saely, C. H.
    Vonbank, A.
    Heinzle, C.
    Zanolin, D.
    Larcher, B.
    Mader, A.
    Leiherer, A.
    Muendlein, A.
    Drexel, H.
    EUROPEAN HEART JOURNAL, 2018, 39 : 293 - 293